Sitero Releases Ash Workflows for Clinical Study Setup and Data Review
Sitero announced in a press release the availability of three Ash agentic workflows for clinical study configuration, data management, and insights. The workflows cover study setup, continuous data review, and portfolio level visibility, with human review required at decision points.
Ash runs on SiteroAI, the company's clinical intelligence engine for GxP environments. SiteroAI brings data from EDC, IRT and RTSM, labs, ePRO, safety databases, and vendor feeds into a governed data layer. The workflows use study specific source data, permission aware access controls, and audit trails, and do not make autonomous clinical, safety, or quality decisions.
Ash for Study Configuration turns an uploaded protocol into a draft study build with visits, forms, fields, codelists, and edit checks. Sitero said the workflow can move a protocol to a live study in two weeks, while also managing amendments, signatures, and eBinder records.
Ash for Data Management supports continuous review, query management, and vendor reconciliation through a data management workbench and Clean Patient Tracker. In an early deployment with a top ten pharmaceutical company, more than 180 data review checks were configured in about five weeks. Ash for Insights adds study and portfolio dashboards for clean patient status, query trends, lock readiness, and database lock forecasting.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 12 DeepSight Technology Adds Scott Huennekens to Board Oct 12 Flo Health Partners With Google Health on Wearables and Women's Health AI Oct 12 Immorta Bio completes preclinical studies of AI designed senolytic peptide Oct 12 POMDOCTOR Outlines Predictive Healthcare Strategy Oct 12 Lunit and Discovery Life Sciences Partner on AI Tissue AnalysisLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
MediSights Reports Study Using AI Agents for Myeloma Market Research
The Saffron Solution Brings AI Workflow Tools to AAO 2026
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Zivian Health Launches Elevate AI Chart Review Tool
Veeva Introduces AI Agent for Clinical Study Configuration
Daily AI Brief: the AI news that matters, in your inbox.